Phillip Frost - Dec 16, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
10%+ Owner
Signature
/s/ Phillip Frost, MD, Individually and as trustee
Stock symbol
BCDA
Transactions as of
Dec 16, 2022
Transactions value $
$1,000,000
Form type
4
Date filed
12/20/2022, 07:15 PM
Previous filing
Nov 23, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $1M +595K +41.61% $1.68 2.03M Dec 16, 2022 See footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock acquired by the Reporting Person from the Issuer in a private placement transaction pursuant to that certain Securities Purchase and Registration Rights Agreement by and among the Issuer and Frost Gamma Investments Trust, dated December 14, 2022.
F2 On June 6, 2019, the Issuer effected a 1-9 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
F3 These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder.